We hypothesized that the increased insulin sensitivity is the main driver of fasting hypoglycemia in GH insensitivity, limiting metabolic counter-regulatory mechanisms such as hypoglycemia-induced EGP promotion and lipolysis. This evidence concerns the gene GH1 and Hypoglycemia.